Fig. 5From: Seven bacterial response-related genes are biomarkers for colon cancerA–E Differential chemotherapeutic response based on the IC50s in the high and low risk score groups. IC50s of five chemotherapeutic agents (dasatinib, obatoclax mesylate, pazopanib, shikonin, and talazoparib)Back to article page